Increased antimicrobial consumption following reimbursement reform in Turkey

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 5, 2008, Pages 1169-1171

  Karabay, Oguz ^a   Hosoglu, Salih ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antibacterial drug screening policy; Antibiotic policy; Antimicrobial agents; Antimicrobial resistance surveillance

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; LINCOSAMIDE DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ARTICLE; CALCULATION; CLASSIFICATION; CONTROLLED STUDY; DATA ANALYSIS; DRUG USE; DRUG UTILIZATION; GOVERNMENT REGULATION; HEALTH CARE PLANNING; METHODOLOGY; PRESCRIPTION; REIMBURSEMENT; SOCIAL INSURANCE; TURKEY (REPUBLIC);

ANTI-BACTERIAL AGENTS; COMMERCE; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PUBLIC POLICY; REIMBURSEMENT MECHANISMS; TIME FACTORS; TURKEY;

EID: 42149087041     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn055     Document Type: Article

References (11)

1. Papova M. Consumption of anti-infective drugs in Bulgaria for the period from 1979 to 1994. Pharm world Sci 1997; 19: 93-100.
2. Hosoglu S, Esen S, Ozturk R et al. The effect of a restriction policy on the antimicrobial consumption in Turkey: A country-wide study. Eur J Clin Pharmacol 2005; 61: 727-31.
3. Semin S, Guldal D, Demiral Y. Globalization and the trends of medical technology trade in Turkey. Health Policy 2007; 81: 320-7.
4. Pharmaceutical Pricing and Reimbursement Information, Turkey, June 2007. http://ppri.oebig.at/Downloads/Results/Turkey_PPRI_2007.pdf (18 November 2007, date last accessed).
5. IMS Health turkey Database. Istanbul-Turkey, 2007.
6. Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). January 2002. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2002.
7. Price D. Impact of antibiotic restrictions: The physician's perspective. Clin Microbiol Infect 2006; 12 Suppl 5: 3-9.
8. Muller A, Coenen S, Monnet D et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe, 1998-2005. Euro Surveill 2007; 12: E071011.1 (http://www.eurosurveillance.org/ew/2007/071011.asp#1).
9. Sener B, Tunçkanat F, Ulusoy S et al. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004-2005. J Antimicrob Chemother 2007; 60: 587-93.
10. Lior C, Bjerrum L. Background for different use of antibiotics in different countries. Clin Infect Dis 2005; 40: 333.
11. Amidi S, Ajamee G, Sadeghi HR et al. Dispensing-drugs without prescription and treating patients by pharmacy attendants in Shiraz, Iran. Am J Public Health 1978; 68: 495-7.